JP2022538148A5 - - Google Patents

Info

Publication number
JP2022538148A5
JP2022538148A5 JP2021576970A JP2021576970A JP2022538148A5 JP 2022538148 A5 JP2022538148 A5 JP 2022538148A5 JP 2021576970 A JP2021576970 A JP 2021576970A JP 2021576970 A JP2021576970 A JP 2021576970A JP 2022538148 A5 JP2022538148 A5 JP 2022538148A5
Authority
JP
Japan
Application number
JP2021576970A
Other languages
Japanese (ja)
Other versions
JPWO2020264269A5 (https=
JP2022538148A (ja
JP7635165B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/039785 external-priority patent/WO2020264269A1/en
Publication of JP2022538148A publication Critical patent/JP2022538148A/ja
Publication of JPWO2020264269A5 publication Critical patent/JPWO2020264269A5/ja
Publication of JP2022538148A5 publication Critical patent/JP2022538148A5/ja
Priority to JP2025020882A priority Critical patent/JP2025081413A/ja
Application granted granted Critical
Publication of JP7635165B2 publication Critical patent/JP7635165B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021576970A 2019-06-27 2020-06-26 p53におけるR175H又はY220C変異を認識するT細胞受容体 Active JP7635165B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025020882A JP2025081413A (ja) 2019-06-27 2025-02-12 p53におけるR175H又はY220C変異を認識するT細胞受容体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962867619P 2019-06-27 2019-06-27
US62/867,619 2019-06-27
PCT/US2020/039785 WO2020264269A1 (en) 2019-06-27 2020-06-26 T cell receptors recognizing r175h or y220c mutation in p53

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025020882A Division JP2025081413A (ja) 2019-06-27 2025-02-12 p53におけるR175H又はY220C変異を認識するT細胞受容体

Publications (4)

Publication Number Publication Date
JP2022538148A JP2022538148A (ja) 2022-08-31
JPWO2020264269A5 JPWO2020264269A5 (https=) 2023-06-29
JP2022538148A5 true JP2022538148A5 (https=) 2023-06-29
JP7635165B2 JP7635165B2 (ja) 2025-02-25

Family

ID=71662353

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021576970A Active JP7635165B2 (ja) 2019-06-27 2020-06-26 p53におけるR175H又はY220C変異を認識するT細胞受容体
JP2025020882A Pending JP2025081413A (ja) 2019-06-27 2025-02-12 p53におけるR175H又はY220C変異を認識するT細胞受容体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025020882A Pending JP2025081413A (ja) 2019-06-27 2025-02-12 p53におけるR175H又はY220C変異を認識するT細胞受容体

Country Status (11)

Country Link
US (1) US12479902B2 (https=)
EP (1) EP3990481A1 (https=)
JP (2) JP7635165B2 (https=)
KR (1) KR20220047969A (https=)
CN (1) CN114341171A (https=)
AU (1) AU2020308004B2 (https=)
BR (1) BR112021026408A2 (https=)
CA (1) CA3144070A1 (https=)
MX (1) MX2021015877A (https=)
TW (2) TWI908730B (https=)
WO (1) WO2020264269A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210189336A1 (en) * 2017-10-18 2021-06-24 Vivia Biotech, S.L. Bite-activated car-t cells
IL305393A (en) 2021-02-25 2023-10-01 Alaunos Therapeutics Inc Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof
US20240209058A1 (en) * 2021-04-30 2024-06-27 Regents Of The University Of Minnesota Mesothelin-specific T cell Receptors and Methods of Using Same
AU2022271195A1 (en) * 2021-05-03 2023-11-02 Bluesphere Bio, Inc. T cell receptors (tcrs) targeting minor histocompatibility antigen ha-1
WO2022236050A1 (en) * 2021-05-07 2022-11-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors recognizing c135y, r175h, or m237i mutation in p53
EP4423143A4 (en) * 2021-10-29 2025-10-01 Yafei Hou T CELL RECEPTOR RECOGNIZING R175H MUTATION IN P53 AND ITS APPLICATION
US20250145950A1 (en) 2022-02-01 2025-05-08 Alaunos Therapeutics, Inc. Methods for Activation and Expansion of T Cells
WO2024076692A1 (en) * 2022-10-05 2024-04-11 Icahn School Of Medicine At Mount Sinai Heterobifunctional compounds as p53 acetylators
WO2024163371A1 (en) * 2023-01-30 2024-08-08 Fred Hutchinson Cancer Center Binding proteins specific for mutant p53 and uses thereof
WO2024206274A2 (en) 2023-03-27 2024-10-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors targeting y220c or r175h mutation in p53
WO2024220520A2 (en) * 2023-04-21 2024-10-24 Board Of Regents, The University Of Texas System T-cell receptors targeting her2 and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003265948B8 (en) 2002-09-06 2009-09-03 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
US8383099B2 (en) 2009-08-28 2013-02-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adoptive cell therapy with young T cells
WO2012129201A1 (en) 2011-03-22 2012-09-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
IL290655B2 (en) 2014-05-29 2024-05-01 Us Health Anti-human papillomavirus 16 E7 T-cell chelates
CN107995913B (zh) 2015-05-18 2022-02-11 T细胞受体治疗公司 使用融合蛋白对tcr重编程的组合物和方法
CN107748893A (zh) * 2017-09-29 2018-03-02 阿里巴巴集团控股有限公司 提升车辆定损图像识别结果的方法、装置及服务器
CA3080274A1 (en) * 2017-09-29 2019-04-04 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods of isolating t cells having antigenic specificity for a p53 cancer-specific mutation
EA202090757A1 (ru) 2017-09-29 2020-08-21 Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез T-КЛЕТОЧНЫЕ РЕЦЕПТОРЫ, РАСПОЗНАЮЩИЕ МУТАНТНЫЙ p53
WO2022236050A1 (en) 2021-05-07 2022-11-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors recognizing c135y, r175h, or m237i mutation in p53
WO2024206274A2 (en) 2023-03-27 2024-10-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors targeting y220c or r175h mutation in p53

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2022538148A5 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
CL2025003474A1 (es) Sales agonistas de sstr4.
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)